Neurovascular Embolization Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Neurovascular Embolization Devices Pipeline Market Report Overview

Neurovascular embolization devices are used to treat abnormalities in blood vessels in the brain, namely, brain aneurysms and arteriovenous malformations (AVM). These devices occlude or prevent blood flow to unwanted vessel malformations. The neurovascular embolization devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The United States

·       China

·       Europe

·       New Zealand

·       Canada

Key Segments ·       Flow Diversion Stents

·       Embolization Coils

·       Liquid Embolic Systems

·       Aneurysm Clips

·       Intrasaccular Flow Disruptors

Key Regulatory Paths ·       510(k)

·       NMPA

·       CE

·       PMA

·       TGA

Leading Companies ·       Alpheus Medical Inc

·       Ancure LLC

·       Aneuclose LLC

·       Artio Medical

·       Avantec Vascular Corp

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Neurovascular Embolization Devices Pipeline Market Segmentation by Segments

The key categories in the ICD pipeline market are aneurysm clips, liquid embolic systems, flow diversion stents, embolization coils, and intrasaccular flow disruptors. As of October 2024, flow diversion stents had the highest number of pipeline products.

Neurovascular Embolization Devices Pipeline Market Analysis by Segments, 2024 (%)

Neurovascular Embolization Devices Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segments Insights into the Neurovascular Embolization Devices Pipeline Market

Download a Free Report Sample

Neurovascular Embolization Devices Pipeline Market Segmentation by Territories

 The key territories associated with the neurovascular embolization devices pipeline market are Europe, the United States, China, New Zealand, and Canada. As of October 2024, the US had the highest number of neurovascular embolization devices pipeline products.

Neurovascular Embolization Devices Pipeline Market Analysis by Territories, 2024 (%)

Neurovascular Embolization Devices Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Neurovascular Embolization Devices Pipeline Market

Download a Free Report Sample

Neurovascular Embolization Devices Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the neurovascular embolization devices pipeline products market are 510(k), NMPA, CE, PMA, and TGA. As of October 2024, 510(k) was the most followed pathway for pipeline products in the neurovascular embolization devices market.

Neurovascular Embolization Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Neurovascular Embolization Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Neurovascular Embolization Devices Pipeline Market

Download a Free Report Sample

Neurovascular Embolization Devices Pipeline Market – Competitive Landscape

A few of the key companies associated with the neurovascular embolization devices pipeline market are Alpheus Medical Inc, Ancure LLC, Aneuclose LLC, Artio Medical, and Avantec Vascular Corp.

Alpheus Medical Inc: Alpheus Medical Inc (Alpheus Medical) focuses on developing a novel sonodynamic therapy platform targeting solid body cancers. It is headquartered in Oakdale, Minnesota, the US.

Aneuclose LLC: Aneuclose LLC (Aneuclose) is a medical technology company that is developing innovative devices and methods to create new options for the treatment of cerebral aneurysms. The company offers products which include intra-aneurysm embolization devicesendovascular parent vessel aneurysm occlusion devicesand novel surgical aneurysm clips. Aneuclose is headquartered in Forest Lake, Minnesota, the US.

Neurovascular Embolization Devices Pipeline Market Analysis by Companies, As of October 2024
Neurovascular Embolization Devices Pipeline Market Analysis by Companies, As of October 2024Buy the Full Report for More Company Insights into the Neurovascular Embolization Devices Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Neurovascular Embolization Devices Pipeline Market Territories Outlook (2024)

  • The United States
  • China
  • Europe
  • New Zealand
  • Canada

Neurovascular Embolization Devices Pipeline Market Category Outlook (2024)

  • Flow Diversion Stents
  • Embolization Coils
  • Liquid Embolic Systems
  • Aneurysm Clips
  • Intrasaccular Flow Disruptors

Neurovascular Embolization Devices Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • NMPA
  • CE
  • Ninsho

Scope

  • Extensive coverage of the neurovascular embolization devices under development.
  • The report reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities.
  • The report reviews the major players involved in the development of neurovascular embolization devices and lists all their pipeline projects.
  • The coverage of pipeline products based on various stages of development ranging from Early Development to approved/issued stage.
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of neurovascular embolization devices under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Alpheus Medical Inc
Ancure LLC
Aneuclose LLC
Artio Medical
Avantec Vascular Corp
Balt USA LLC
BioCure Inc
Cerenovus
Cerus Endovascular Ltd
Codman & Shurtleff Inc
Corindus Vascular Robotics Inc
Dartmouth College
DePuy Synthes Inc
Dongguan Tiantianxiang Medical Technology Co Ltd
eLUM Technologies Inc
EnCompass Technologies, Inc
Endomimetics LLC
EndoShape, Inc. (Inactive)
EndoStream Medical Ltd
Evasc Medical Systems Corp
Fluid Biotech Inc
Fluidx Medical Technology LLC
Guichuangtongqiao Medical Technology Co Ltd
HeMo Bioengineering Ltd
Integra LifeSciences Holdings Corp
Jiangsu Nuanyang Medical Instrument Co Ltd
Mayo Clinic
Medtronic Plc
MicroPort NeuroScientific Corp
MicroVention Inc
Monarch Biosciences Inc
NEOS Surgery SL
Neurosigma Inc
OccluTex Medical BV
OrbusNeich
Oxford Endovascular Ltd
Peijia Medical Ltd
Qvanteq AG
Regenity Biosciences
Sequent Medical, Inc.
Shanghai Healing Medical Instruments Co Ltd
Shanghai HeartCare Medical Technology Co Ltd
Shape Memory Medical Inc
Silk Road Medical Inc
Sinomed Neurovita Technology Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Stryker Corp
Stryker Neurovascular
Suzhou Zhongtian Medical Device Technology Co Ltd
Transverse Medical Inc
University of California Los Angeles
University of Minnesota
University of Wisconsin Madison
Weill Cornell Medical College
Zylox-Tonbridge Medical Technology Co Ltd

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Neurovascular Embolization Devices Overview

3 Products under Development

3.1 Neurovascular Embolization Devices – Pipeline Products by Stage of Development

3.2 Neurovascular Embolization Devices – Pipeline Products by Segment

3.3 Neurovascular Embolization Devices – Pipeline Products by Territory

3.4 Neurovascular Embolization Devices – Pipeline Products by Regulatory Path

3.5 Neurovascular Embolization Devices – Pipeline Products by Estimated Approval Date

3.6 Neurovascular Embolization Devices – Ongoing Clinical Trials

4 Neurovascular Embolization Devices – Pipeline Products under Development by Companies

4.1 Neurovascular Embolization Devices Companies – Pipeline Products by Stage of Development

4.2 Neurovascular Embolization Devices – Pipeline Products by Stage of Development

5 Neurovascular Embolization Devices Companies and Product Overview

5.1 Alpheus Medical Inc Company Overview

5.1.1 Alpheus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.2 Ancure LLC Company Overview

5.2.1 Ancure LLC Pipeline Products & Ongoing Clinical Trials Overview

5.3 Aneuclose LLC Company Overview

5.3.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview

5.4 Artio Medical Company Overview

5.4.1 Artio Medical Pipeline Products & Ongoing Clinical Trials Overview

5.5 Avantec Vascular Corp Company Overview

5.5.1 Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview

5.6 Balt USA LLC Company Overview

5.6.1 Balt USA LLC Pipeline Products & Ongoing Clinical Trials Overview

5.7 BioCure Inc Company Overview

5.7.1 BioCure Inc Pipeline Products & Ongoing Clinical Trials Overview

5.8 Cerenovus Company Overview

5.8.1 Cerenovus Pipeline Products & Ongoing Clinical Trials Overview

5.9 Cerus Endovascular Ltd Company Overview

5.9.1 Cerus Endovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.10 Codman & Shurtleff Inc Company Overview

5.10.1 Codman & Shurtleff Inc Pipeline Products & Ongoing Clinical Trials Overview

5.11 Corindus Vascular Robotics Inc Company Overview

5.11.1 Corindus Vascular Robotics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.12 Dartmouth College Company Overview

5.12.1 Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview

5.13 DePuy Synthes Inc Company Overview

5.13.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview

5.14 Dongguan Tiantianxiang Medical Technology Co Ltd Company Overview

5.14.1 Dongguan Tiantianxiang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.15 eLUM Technologies Inc Company Overview

5.15.1 eLUM Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.16 EnCompass Technologies, Inc Company Overview

5.16.1 EnCompass Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview

5.17 Endomimetics LLC Company Overview

5.17.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.18 EndoShape, Inc. (Inactive) Company Overview

5.18.1 EndoShape, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.19 EndoStream Medical Ltd Company Overview

5.19.1 EndoStream Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.20 Evasc Medical Systems Corp Company Overview

5.20.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview

5.21 Fluid Biotech Inc Company Overview

5.21.1 Fluid Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview

5.22 Fluidx Medical Technology LLC Company Overview

5.22.1 Fluidx Medical Technology LLC Pipeline Products & Ongoing Clinical Trials Overview

5.23 Guichuangtongqiao Medical Technology Co Ltd Company Overview

5.23.1 Guichuangtongqiao Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.24 HeMo Bioengineering Ltd Company Overview

5.24.1 HeMo Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.25 Integra LifeSciences Holdings Corp Company Overview

5.25.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview

5.26 Jiangsu Nuanyang Medical Instrument Co Ltd Company Overview

5.26.1 Jiangsu Nuanyang Medical Instrument Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.27 Mayo Clinic Company Overview

5.27.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview

5.28 Medtronic Plc Company Overview

5.28.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

5.29 MicroPort NeuroScientific Corp Company Overview

5.29.1 MicroPort NeuroScientific Corp Pipeline Products & Ongoing Clinical Trials Overview

5.30 MicroVention Inc Company Overview

5.30.1 MicroVention Inc Pipeline Products & Ongoing Clinical Trials Overview

5.31 Monarch Biosciences Inc Company Overview

5.31.1 Monarch Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

5.32 NEOS Surgery SL Company Overview

5.32.1 NEOS Surgery SL Pipeline Products & Ongoing Clinical Trials Overview

5.33 Neurosigma Inc Company Overview

5.33.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview

5.34 OccluTex Medical BV Company Overview

5.34.1 OccluTex Medical BV Pipeline Products & Ongoing Clinical Trials Overview

5.35 OrbusNeich Company Overview

5.35.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview

5.36 Oxford Endovascular Ltd Company Overview

5.36.1 Oxford Endovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.37 Peijia Medical Ltd Company Overview

5.37.1 Peijia Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.38 Qvanteq AG Company Overview

5.38.1 Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview

5.39 Regenity Biosciences Company Overview

5.39.1 Regenity Biosciences Pipeline Products & Ongoing Clinical Trials Overview

5.40 Sequent Medical, Inc. Company Overview

5.40.1 Sequent Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.41 Shanghai Healing Medical Instruments Co Ltd Company Overview

5.41.1 Shanghai Healing Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.42 Shanghai HeartCare Medical Technology Co Ltd Company Overview

5.42.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.43 Shape Memory Medical Inc Company Overview

5.43.1 Shape Memory Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.44 Silk Road Medical Inc Company Overview

5.44.1 Silk Road Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.45 Sinomed Neurovita Technology Inc Company Overview

5.45.1 Sinomed Neurovita Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

5.46 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview

5.46.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

5.47 Stryker Corp Company Overview

5.47.1 Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview

5.48 Stryker Neurovascular Company Overview

5.48.1 Stryker Neurovascular Pipeline Products & Ongoing Clinical Trials Overview

5.49 Suzhou Zhongtian Medical Device Technology Co Ltd Company Overview

5.49.1 Suzhou Zhongtian Medical Device Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.50 Transverse Medical Inc Company Overview

5.50.1 Transverse Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.51 University of California Los Angeles Company Overview

5.51.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

5.52 University of Minnesota Company Overview

5.52.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview

5.53 University of Wisconsin Madison Company Overview

5.53.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview

5.54 Weill Cornell Medical College Company Overview

5.54.1 Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview

5.55 Zylox-Tonbridge Medical Technology Co Ltd Company Overview

5.55.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Neurovascular Embolization Devices- Recent Developments

6.1 Sep 09, 2024: Stryker Neurovascular Receives Additional FDA 510(k) Clearance for Target Detachable Coil

6.2 Sep 05, 2024: Johnson & Johnson Appoints Christian Rodseth as North Asia Managing Director

6.3 Aug 30, 2024: MicroPort Scientific Reports Earnings Results for the Half Year Ended June 30, 2024

6.4 Aug 28, 2024: Achieva Medical Entered into an Exclusive Distribution Agreement with NowYon Medical

6.5 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.6 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.7 Aug 26, 2024: Johnson & Johnson Taps New Chief Human Resources Officer

6.8 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance

6.9 Jul 23, 2024: MicroVention Announces Release of CLinical EValuation of WEB 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms

6.10 Jul 10, 2024: MicroPort NeuroTech’s NUMEN Coil Receives Reimbursement Approval in France and Completes Initial Commercial Implantations

6.11 Jul 02, 2024: Penumbra Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024

6.12 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024

6.13 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024

6.14 Jun 13, 2024: Medtronic Confirms Global Layoffs

6.15 Jun 04, 2024: Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

6.16 Apr 22, 2024: Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)

6.17 Apr 02, 2024: MicroPort NeuroTech Announces Publication of Safety Study Results for Tubridge in Treating Intracranial Aneurysms

6.18 Apr 02, 2024: Johnson & Johnson to Participate in the BofA Securities Health Care Conference

6.19 Mar 28, 2024: Microport Neurotech Completes the First Commercial Implantation of Tubridge Flow Diverter in Argentina

6.20 Mar 28, 2024: CERENOVUS Expands Minimally Invasive Stroke Care Innovation with New Liquid Embolic System Procedural Set

6.21 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

6.22 Mar 01, 2024: Embolx Receives 510(K) Clearance For Soldier Microcatheter

6.23 Feb 29, 2024: New Soldier High Flow Microcatheter Granted FDA Clearance

6.24 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company

6.25 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering

6.26 Feb 14, 2024: Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference

6.27 Feb 12, 2024: New Research Shows Minimally Invasive Therapy (Middle Meningeal Artery Embolization) is Effective in Treating Chronic Subdural Hematoma

6.28 Feb 09, 2024: New Late Breaking Preliminary Data Demonstrate Balt’s Squid Liquid Embolic May Improve Outcomes in Patients With Chronic Subdural Hematomas

6.29 Jan 29, 2024: MicroPort NeuroTech Receives Additional 510(K) Clearance For NUMEN FR Coil Detachment System

6.30 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results

6.31 Dec 07, 2023: Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

6.32 Dec 06, 2023: MicroPort NeuroTech Completes the First Batch of Clinical Implantations of NUMEN in Japan

6.33 Nov 30, 2023: Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses

6.34 Oct 09, 2023: Stryker to Host Investor Day

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Neurovascular Embolization Devices – Pipeline Products by Stage of Development

Neurovascular Embolization Devices – Pipeline Products by Segment

Neurovascular Embolization Devices – Pipeline Products by Territory

Neurovascular Embolization Devices – Pipeline Products by Regulatory Path

Neurovascular Embolization Devices – Pipeline Products by Estimated Approval Date

Neurovascular Embolization Devices – Ongoing Clinical Trials

Neurovascular Embolization Devices Companies – Pipeline Products by Stage of Development

Neurovascular Embolization Devices – Pipeline Products by Stage of Development

Alpheus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Brain Aneurysm Clip – Product Status

Brain Aneurysm Clip – Product Description

Ancure LLC Pipeline Products & Ongoing Clinical Trials Overview

Drug-Eluting Embolization Coil – Product Status

Drug-Eluting Embolization Coil – Product Description

Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview

Janjua Aneurysm Net – Product Status

Janjua Aneurysm Net – Product Description

Artio Medical Pipeline Products & Ongoing Clinical Trials Overview

Ballstent Microcatheter – Product Status

Ballstent Microcatheter – Product Description

Endura Embolization Coils – Product Status

Endura Embolization Coils – Product Description

Endura Embolization Device – Product Status

Endura Embolization Device – Product Description

Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview

Endovascular Embolization Device – Product Status

Endovascular Embolization Device – Product Description

Balt USA LLC Pipeline Products & Ongoing Clinical Trials Overview

Squid Liquid Embolic Device – Product Status

Squid Liquid Embolic Device – Product Description

BioCure Inc Pipeline Products & Ongoing Clinical Trials Overview

GelCoil – Product Status

GelCoil – Product Description

LiquiGel – Product Status

LiquiGel – Product Description

Cerenovus Pipeline Products & Ongoing Clinical Trials Overview

Self-Expanding Stent – Product Status

Self-Expanding Stent – Product Description

Cerus Endovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview

Neqstent Coil Assisted Flow Diverter Device – Product Status

Neqstent Coil Assisted Flow Diverter Device – Product Description

Codman & Shurtleff Inc Pipeline Products & Ongoing Clinical Trials Overview

TRUFILL n-BCA Liquid Embolic System – Chronic Subdural Hematoma – Product Status

TRUFILL n-BCA Liquid Embolic System – Chronic Subdural Hematoma – Product Description

Codman & Shurtleff Inc – Ongoing Clinical Trials Overview

TRUFILL n-BCA Liquid Embolic System – Chronic Subdural Hematoma – Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas with TRUFILL n-BCA

Corindus Vascular Robotics Inc Pipeline Products & Ongoing Clinical Trials Overview

CorPath GRX Neurovascular System – Product Status

CorPath GRX Neurovascular System – Product Description

Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview

Cerebral Aneurysm Clip – Product Status

Cerebral Aneurysm Clip – Product Description

DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview

Liquid Embolic System – Product Status

Liquid Embolic System – Product Description

Dongguan Tiantianxiang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

All-in-One Neuroembolic Retriever – Product Status

All-in-One Neuroembolic Retriever – Product Description

eLUM Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Distal Embolic Protection System – Product Status

Distal Embolic Protection System – Product Description

Pipeline Shield – Product Status

Pipeline Shield – Product Description

EnCompass Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview

F2 Cerebral Embolic Filter – Product Status

F2 Cerebral Embolic Filter – Product Description

EnCompass Technologies, Inc – Ongoing Clinical Trials Overview

F2 Cerebral Embolic Filter – A Prospective, Single-Arm, Multicenter Feasibility Trial to Evaluate the Safety and Performance of the F2 Filter and Delivery System Used for Embolic Protection During Transcatheter Aortic Valve Replacement

F2 Cerebral Embolic Filter – A Prospective, Single-arm, Multicenter Feasibility Trial to Evaluate the Safety and Performance of the F2 Filter and Delivery System Used for Embolic Protection During Transcatheter Aortic Valve Replacement

F2 Cerebral Embolic Filter – A Prospective, Single-Arm, Single Center Feasibility Trial to Evaluate the Safety and Performance of the F2 Filter and Delivery System Used for Embolic Protection During Transcatheter Aortic Valve Replacement

Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview

Blood Flow Diverter – Product Status

Blood Flow Diverter – Product Description

EndoShape, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Next Generation Neurovascular Device – Radiopaque SMP – Product Status

Next Generation Neurovascular Device – Radiopaque SMP – Product Description

EndoStream Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

Nautilus Intrasaccular System – Product Status

Nautilus Intrasaccular System – Product Description

EndoStream Medical Ltd – Ongoing Clinical Trials Overview

Nautilus Intrasaccular System – A Study to Evaluate the Nautilus Intrasaccular System to Treat Cerebral Aneurysms

Nautilus Intrasaccular System – Nautilus Endovascular Device for Wide Neck Cerebral Aneurysm Embolization Study

Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview

Second Generation eCLIPs System – Product Status

Second Generation eCLIPs System – Product Description

Fluid Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview

Flow-Diverting Brain Stent – Product Status

Flow-Diverting Brain Stent – Product Description

Fluidx Medical Technology LLC Pipeline Products & Ongoing Clinical Trials Overview

GPX Embolic Device – Product Status

GPX Embolic Device – Product Description

IMPASS Embolic Device – Product Status

IMPASS Embolic Device – Product Description

Fluidx Medical Technology LLC – Ongoing Clinical Trials Overview

GPX Embolic Device – Evaluation of a Simple-Prep Controlled Embolic (GPX Trial)

Guichuangtongqiao Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Blood Flow Diversion Device – Product Status

Blood Flow Diversion Device – Product Description

Intracranial Aneurysm Embolization Coil – Product Status

Intracranial Aneurysm Embolization Coil – Product Description

HeMo Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview

Flow Diverter – Hemorrhagic Stroke – Product Status

Flow Diverter – Hemorrhagic Stroke – Product Description

Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview

Deltapaq Microcoil – Product Status

Deltapaq Microcoil – Product Description

Flow Diverter – Product Status

Flow Diverter – Product Description

Jiangsu Nuanyang Medical Instrument Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

YonFlow Blood Flow Steering Stent System – Product Status

YonFlow Blood Flow Steering Stent System – Product Description

Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview

Tissue-Derived Bioactive Gel – Product Status

Tissue-Derived Bioactive Gel – Product Description

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

Artisse Intrasaccular Device – Product Status

Artisse Intrasaccular Device – Product Description

Intrasaccular Device – Hemorrhagic Stroke – Product Status

Intrasaccular Device – Hemorrhagic Stroke – Product Description

Onyx Liquid Embolic System – Middle Meningeal Arterial Embolization – Product Status

Onyx Liquid Embolic System – Middle Meningeal Arterial Embolization – Product Description

Medtronic Plc – Ongoing Clinical Trials Overview

Artisse Intrasaccular Device – Artisse™ Intrasaccular Device IDE

Onyx Liquid Embolic System – Middle Meningeal Arterial Embolization – Managing Non-acute Subdural Hematoma Using Liquid Materials: A Chinese Randomized Trial of MMA Treatment

Onyx Liquid Embolic System – Middle Meningeal Arterial Embolization – The Onyx Trial for the Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma (OTEMACS)

MicroPort NeuroScientific Corp Pipeline Products & Ongoing Clinical Trials Overview

Embolization Coil – Product Status

Embolization Coil – Product Description

Tubridge Plus Flowdiverting Stent – Product Status

Tubridge Plus Flowdiverting Stent – Product Description

MicroPort NeuroScientific Corp – Ongoing Clinical Trials Overview

Tubridge Plus Flowdiverting Stent – Prospective, Multi-Center, Open-Label, Single-Arm Registration Trial Of The Tubridge Plus For The Treatment Of Wide-Necked Intracranial Aneurysms

MicroVention Inc Pipeline Products & Ongoing Clinical Trials Overview

Advanced Coil – Product Status

Advanced Coil – Product Description

Monarch Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

Titan Flow Diverter – Product Status

Titan Flow Diverter – Product Description

NEOS Surgery SL Pipeline Products & Ongoing Clinical Trials Overview

Aneurysm Clip – Product Status

Aneurysm Clip – Product Description

Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview

Thin Film Nitinol Flow Diverting Stent – Product Status

Thin Film Nitinol Flow Diverting Stent – Product Description

OccluTex Medical BV Pipeline Products & Ongoing Clinical Trials Overview

OccluTex – Product Status

OccluTex – Product Description

OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview

Flow Diverter Device – Product Status

Flow Diverter Device – Product Description

Oxford Endovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview

Oxiflow – Product Status

Oxiflow – Product Description

Peijia Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

Detachable Coil (Thermal Detachment) – Product Status

Detachable Coil (Thermal Detachment) – Product Description

Jasper Detachable Coil II – Product Status

Jasper Detachable Coil II – Product Description

Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview

Qstent Neurovascular Stent – Product Status

Qstent Neurovascular Stent – Product Description

Regenity Biosciences Pipeline Products & Ongoing Clinical Trials Overview

Collagen-Based Coils – Product Status

Collagen-Based Coils – Product Description

Sequent Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Advanced WEB Aneurysm Embolization Device – Product Status

Advanced WEB Aneurysm Embolization Device – Product Description

Shanghai Healing Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Embolectomy Catheter – Product Status

Embolectomy Catheter – Product Description

Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Aneurysm Embolization System – Product Status

Aneurysm Embolization System – Product Description

Flow Diverter Device – Product Status

Flow Diverter Device – Product Description

Shape Memory Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

TrelliX Embolic Coil System – Product Status

TrelliX Embolic Coil System – Product Description

Silk Road Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Novis Transcarotid Neuroprotection System – Product Status

Novis Transcarotid Neuroprotection System – Product Description

Sinomed Neurovita Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

Flow Diverter Stent System – Product Status

Flow Diverter Stent System – Product Description

Sinomed Neurovita Technology Inc – Ongoing Clinical Trials Overview

Flow Diverter Stent System – A Prospective, Multi-center, Single Arm Clinical Study to Evaluate the Safety and Effectiveness of the Flow Diverter Stent System in the Treatment of Cerebral Aneurysms

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

Flow Diverter Stent – Product Status

Flow Diverter Stent – Product Description

Radiopaque Liquid Embolization Device – Product Status

Radiopaque Liquid Embolization Device – Product Description

Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview

Surpass Elite – Product Status

Surpass Elite – Product Description

Stryker Neurovascular Pipeline Products & Ongoing Clinical Trials Overview

Citadel Embolization Device – Product Status

Citadel Embolization Device – Product Description

Stryker Neurovascular – Ongoing Clinical Trials Overview

Citadel Embolization Device – The Citadel Embolization Device Feasibility Study

Suzhou Zhongtian Medical Device Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Embolic Stent – Product Status

Embolic Stent – Product Description

Transverse Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

POINT-GUARD – Product Status

POINT-GUARD – Product Description

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

Bioactive Endovascular Coil System – Product Status

Bioactive Endovascular Coil System – Product Description

Dual Rotational Stent – Product Status

Dual Rotational Stent – Product Description

University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview

Vascular Embolization Catheter – Product Status

Vascular Embolization Catheter – Product Description

University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview

Bioactive Endovascular Device – Product Status

Bioactive Endovascular Device – Product Description

Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview

Sphere – Bifurcation Aneurysm Flow-Diverting Device – Product Status

Sphere – Bifurcation Aneurysm Flow-Diverting Device – Product Description

Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Mechanical Detachable Coil II – Product Status

Mechanical Detachable Coil II – Product Description

Glossary

Figures

Neurovascular Embolization Devices – Pipeline Products by Stage of Development

Neurovascular Embolization Devices – Pipeline Products by Segment

Neurovascular Embolization Devices – Pipeline Products by Territory

Neurovascular Embolization Devices – Pipeline Products by Regulatory Path

Neurovascular Embolization Devices – Pipeline Products by Estimated Approval Date

Neurovascular Embolization Devices – Ongoing Clinical Trials

Frequently asked questions

Neurovascular Embolization Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Neurovascular Embolization Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Neurovascular Embolization Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Neurovascular Embolization Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.